Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

(R)-Doxylaminium (R,R)-tartrate.

ABSTRACT:

In the title compound (systematic name

(R)-dimeth-yl{2-[1-phenyl-1-(pyridin-2-yl)eth-oxy]eth-yl}aza-nium (R,R)-3-carb-oxy-2,3-dihy-droxy-propano-ate), C(17)H(23)N(2)O(+)·C(4)H(5)O(6) (-), the doxylaminium cation is protonated at the N atom. The tartrate monoanions are linked by short, almost linear O-H?O hydrogen bonds into chains extended along [100]. These chains are inter-linked by anion-pyridine O-H?N hydrogen bonds into a two-dimensional grid structure. WeakC-H?O inter-actions also play a role in the crystal packing. An intra-molecular hy-droxy-carboxyl-ate O-H?O hydrogen bond influences the conformation of the anion: the hydrogen-bonded fragment is almost planar, the maximum deviation from the mean plane being 0.059?(14)?Å. In the cation, the aromatic rings are almost perpendicular [dihedral angle = 84.94?(8)°] and the conformation of the O-C-C-N chain is gauche(-), the dihedral angle is -76.6?(2)°. The absolute configuration was assigned on the basis of known chirality of the parent compound.

SUBMITTER: Dayananda AS

PROVIDER: S-EPMC3344015 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

(R)-Doxylaminium (R,R)-tartrate.

Dayananda A S AS Dutkiewicz Grzegorz G Yathirajan H S HS Kubicki Maciej M

Acta crystallographica. Section E, Structure reports online 20120314 Pt 4

<h4>In the title compound (systematic name</h4>(R)-dimeth-yl{2-[1-phenyl-1-(pyridin-2-yl)eth-oxy]eth-yl}aza-nium (R,R)-3-carb-oxy-2,3-dihy-droxy-propano-ate), C(17)H(23)N(2)O(+)·C(4)H(5)O(6) (-), the doxylaminium cation is protonated at the N atom. The tartrate monoanions are linked by short, almost linear O-H⋯O hydrogen bonds into chains extended along [100]. These chains are inter-linked by anion-pyridine O-H⋯N hydrogen bonds into a two-dimensional grid structure. WeakC-H⋯O inter-actions also ...[more]

PMID: 22589924

Similar Datasets

Flupentixol tartrate.

Project description:In the title salt, C23H26F3N2OS(+)·C4H5O6 (-) [systematic name: 1-(2-hy-droxy-eth-yl)-4-[3-(2-(tri-fluoro-meth-yl)thioxanthen-9-yl-idene)prop-yl]piperazin-1-ium 3-carb-oxy-2,3-di-hydroxy-pro-pion-ate], the monoprotonated piperazine ring in the cation adopts a chair conformation, while the thio-pyran ring of the thioxanthene group has a boat conformation. The dihedral angle between the mean planes of the two outer aromatic rings of the thioxanthene groups is 31.6 (2)°. In the crystal, the cations and anions are linked via O-H⋯O, N-H⋯O, O-H⋯N and C-H⋯O hydrogen bonds, forming chains propagating along [100]. In addition, R (2) 2(7), R (2) 2(11), R (2) 2(10) and R (2) 2(12) graph-set ring motifs involving the anions, and R (2) 2(9) graph-set ring motifs involving both the cations and anions are observed. The three F atoms of the tri-fluoro-methyl group are disordered over two sets of sites and the individual atoms were refined with occupancy ratios of 0.54 (6):0.46 (6), 0.72 (2):0.28 (2) and 0.67 (3):0.33 (3).

| S-EPMC3998353 | biostudies-literature

Disodium (2RS,3SR)-tartrate.

Project description:The asymmetric unit of the anhydrous title compound, 2Na(+)·C(4)H(4)O(6) (2-), contains two sodium cations and one tartrate anion. Each sodium ion is six coordinate, with bonding to six O atoms from both the carboxyl-ate and hydroxyl groups of the anion. A three-dimensional coordination network is formed with sodium ions stacking in layers along the c-axis direction. This network is supported by additional O-H?O hydrogen bonds.

| S-EPMC2970502 | biostudies-literature

Bis(melaminium) tartrate dihydrate.

Project description:In the title compound, 2C(3)H(7)N(6) (+)·C(4)H(4)O(6) (2-)·2H(2)O, in which the complete anion is generated by crystallographic twofold symmetry, there are O-H⋯O, N-H⋯O and N-H⋯N hydrogen-bonding inter-actions between neighbouring moieties, forming layers parallel to the bc plane. In addition, π-π contacts [centroid-centroid distance = 3.6541 (9) Å] between the six-membered rings of the melamine cations are observed.

| S-EPMC2968909 | biostudies-literature

Morpholin-4-ium hydrogen tartrate.

Project description:In the title mol-ecular salt, C(4)H(10)NO(+)·C(4)H(5)O(6) (-), the morpholinium cation adopts a chair conformation. The conformation of the C-C-C-C backbone of the monotartrate anion is close to anti [torsion angle = 173.18 (17)°], which is supported by two intra-molecular O-H⋯O hydrogen bonds. In the crystal, the components are linked by N-H-O and O-H-O hydrogen bonds, generating (001) sheets.

| S-EPMC3274983 | biostudies-literature

Morpholin-4-ium hydrogen l-tartrate monohydrate.

Project description:In the title compound, C(4)H(10)NO(+)·C(4)H(5)O(6) (-)·H(2)O, the morpholine ring adopts a chair conformation. In the crystal, the tartrate anions are linked via O-H⋯O hydrogen bonds, forming chains propagating along [101]. These chains are linked via N-H⋯O and O-H⋯O hydrogen bonds, involving the morpholinium cation and the water molecule, forming a three-dimensional network.

| S-EPMC3274992 | biostudies-literature

Crystal structure of lead(II) tartrate: a redetermination.

Project description:Single crystals of poly[μ4-tartrato-κ(6) O (1),O (3):O (1'):O (2),O (4):O (4')-lead], [Pb(C4H4O6)] n , were grown in a gel medium. In comparison with the previous structure determination of this compound from laboratory powder X-ray diffraction data [De Ridder et al. (2002 ▶). Acta Cryst. C58, m596-m598], the redetermination on the basis of single-crystal data reveals the absolute structure, all atoms with anisotropic displacement parameters and a much higher accuracy in terms of bond lengths and angles. It could be shown that a different space group or incorporation of water as reported for similarly gel-grown lead tartrate crystals is incorrect. In the structure, each Pb(2+) cation is bonded to eight O atoms of five tartrate anions, while each tartrate anion links four Pb(2+) cations. The resulting three-dimensional framework is stabilized by O-H⋯O hydrogen bonds between the OH groups of one tartrate anion and the carboxyl-ate O atoms of adjacent anions.

| S-EPMC4331892 | biostudies-literature

Bis(2,6-diamino-pyridinium) tartrate monohydrate.

Project description:In the title compound, 2C(5)H(8)N(3) (+)·C(4)H(4)O(6) (2-)·H(2)O, the two cations are essentially planar [maximum deviations = 0.023?(1) and 0.026?(1)?Å]. In one of the cations, the protonated N atom and one of the amino group H atoms are hydrogen bonded to one of the carboxyl groups of the dianion through a pair of N-H?O hydrogen bonds, forming an R(2) (2)(8) ring motif. In the crystal structure, the tartrate anions and water mol-ecules are linked into chains along the c axis by inter-molecular O-H?O and C-H?O hydrogen bonds. The cations further link the anions and water mol-ecules into a three-dimensional extended structure by a network of N-H?O hydrogen bonds. The crystal structure is also stabilized by weak inter-molecular ?-? inter-actions [centroid-centroid distance = 3.6950?(6)?Å].

| S-EPMC2971208 | biostudies-other

1,10-Phenanthrolin-1-ium hydrogen d,l-tartrate dihydrate.

Project description:In the title hydrated molecular salt, C(12)H(9)N(2) (+)·C(4)H(5)O(6) (-)·2H(2)O, the cation is almost planar (r.m.s. deviation = 0.014?Å); the carbon skeleton of the anion assumes a trans conformation [C-C-C-C torsion angle = -179.86?(14)°]. The carboxyl end of one hydrogen tartrate anion forms a short hydrogen bond to the carboxyl-ate end of another anion [O?O = 2.508?(2)?Å] in a head-to-tail manner, forming a chain; the chains and water mol-ecules inter-act, generating an O-H?O hydrogen-bonded layer. The cation binds to the layer by an N-H?O hydrogen bond.

| S-EPMC3120439 | biostudies-literature

Monomeric tartrate resistant acid phosphatase induces insulin sensitive obesity.

Project description:BackgroundObesity is associated with macrophage infiltration of adipose tissue, which may link adipose inflammation to insulin resistance. However, the impact of inflammatory cells in the pathophysiology of obesity remains unclear. Tartrate resistant acid phosphatase (TRAP) is an enzyme expressed by subsets of macrophages and osteoclasts that exists either as an enzymatically inactive monomer or as an active, proteolytically processed dimer.Principal findingsUsing mice over expressing TRAP, we show that over-expression of monomeric, but not the dimeric form in adipose tissue leads to early onset spontaneous hyperplastic obesity i.e. many small fat cells. In vitro, recombinant monomeric, but not proteolytically processed TRAP induced proliferation and differentiation of mouse and human adipocyte precursor cells. In humans, monomeric TRAP was highly expressed in the adipose tissue of obese individuals. In both the mouse model and in the obese humans the source of TRAP in adipose tissue was macrophages. In addition, the obese TRAP over expressing mice exhibited signs of a low-grade inflammatory reaction in adipose tissue without evidence of abnormal adipocyte lipolysis, lipogenesis or insulin sensitivity.ConclusionMonomeric TRAP, most likely secreted from adipose tissue macrophages, induces hyperplastic obesity with normal adipocyte lipid metabolism and insulin sensitivity.

| S-EPMC2248616 | biostudies-literature

Profile of eliglustat tartrate in the management of Gaucher disease.

Project description:Gaucher disease (GD) is a lysosomal storage disorder caused by the deficient activity of acid beta glucosidase, with consequent accumulation of glucosylceramide in the spleen, liver, bone marrow, and various organs and tissues. Currently, the gold standard for GD treatment is enzyme replacement therapy (ERT). The efficacy of ERT in improving or stabilizing the visceral and hematological symptoms of GD is well-proven. However, since ERT has to be administered by frequent intravenous infusions, this therapeutic approach has an important impact on the patient's quality of life. Eliglustat tartrate is a new substrate reduction therapy for GD, which acts as a specific and potent inhibitor of glucosylceramide synthase and can be administered orally. This review summarizes the results of the preclinical and clinical trials, which experimented with eliglustat, and discusses its possible role in the management of GD, when compared to the currently available treatments and the new experimental approaches.

| S-EPMC4714736 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data